Machine Learning Platform Can Accurately Predict Onset of MS, Maker Says

IQuity, a data analytics company, announced the launch of an analytics platform that uses machine learning to predict, identify, and monitor chronic disease within large populations of patients, including multiple sclerosis (MS). The platform was validated using a pilot study that assessed the healthcare claims of 20 million people in New York, which encompassed four billion data points. IQuity focused on using these data to predict the onset of MS.